SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

IQVIA Holdings Inc., et al. – ‘S-4’ on 1/5/24 – ‘EX-5.1’

On:  Friday, 1/5/24, at 4:33pm ET   ·   Accession #:  1193125-24-3405   ·   File #s:  333-276404, -01, -02, -03, -04, -05, -06, -07, -08, -09, -10, -11, -12, -13, -14, -15, -16, -17, -18, -19, -20, -21, -22, -23, -24, -25, -26, -27, -28, -29, -30, -31, -32, -33, -34, -35

Previous ‘S-4’:  ‘S-4/A’ on 8/11/16   ·   Next & Latest:  ‘S-4/A’ on 1/18/24   ·   23 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/05/24  IQVIA Holdings Inc.               S-4                   84:6.3M                                   Donnelley … Solutions/FA
          Q Squared Solutions Holdings LLC
          Innovex Merger Corp.
          Med-Vantage, Inc.
          BuzzeoPDMA LLC
          Data Niche Associates, Inc.
          IQVIA Inc.
          IMS Software Services Ltd.
          Intercontinental Medical Statistics International, Ltd.
          IQVIA BioSciences Holdings, LLC
          IQVIA Biotech LLC
          IQVIA Chinametrik Inc.
          IQVIA Commercial Finance Inc.
          IQVIA Commercial India Holdings Corp.
          IQVIA Commercial Trading Corp.
          IQVIA Government Solutions Inc.
          QCare Site Services, Inc.
          IQVIA Trading Management Inc.
          IQVIA RDS Latin America LLC
          IQVIA RDS Inc.
          IQVIA RDS Asia Inc.
          IQVIA Phase One Services LLC
          IQVIA Pharma Services Corp.
          IQVIA Pharma Inc.
          IQVIA Medical Education Inc.
          IQVIA Medical Communications & Consulting, Inc.
          IQVIA Transportation Services Corp.
          IQVIA CSMS US Inc.
          RX India, LLC
          Targeted Molecular Diagnostics, LLC
          ValueMedics Research, LLC
          VCG&A, Inc.
          VCG-Bio, Inc.
          Q Squared Solutions LLC
          Outcome Sciences, LLC
          Benefit Holding, Inc.

Registration Statement – Securities for a Merger   —   Form S-4   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4         Registration Statement - Securities for a Merger    HTML    946K 
 9: EX-3.10     Articles of Incorporation/Organization or Bylaws    HTML     95K 
10: EX-3.11     Articles of Incorporation/Organization or Bylaws    HTML     42K 
11: EX-3.12     Articles of Incorporation/Organization or Bylaws    HTML     51K 
12: EX-3.13     Articles of Incorporation/Organization or Bylaws    HTML     44K 
13: EX-3.14     Articles of Incorporation/Organization or Bylaws    HTML     81K 
14: EX-3.15     Articles of Incorporation/Organization or Bylaws    HTML     41K 
15: EX-3.16     Articles of Incorporation/Organization or Bylaws    HTML     52K 
16: EX-3.17     Articles of Incorporation/Organization or Bylaws    HTML     33K 
17: EX-3.18     Articles of Incorporation/Organization or Bylaws    HTML     60K 
18: EX-3.19     Articles of Incorporation/Organization or Bylaws    HTML     34K 
19: EX-3.20     Articles of Incorporation/Organization or Bylaws    HTML     61K 
20: EX-3.21     Articles of Incorporation/Organization or Bylaws    HTML     42K 
21: EX-3.22     Articles of Incorporation/Organization or Bylaws    HTML     51K 
22: EX-3.23     Articles of Incorporation/Organization or Bylaws    HTML     59K 
23: EX-3.24     Articles of Incorporation/Organization or Bylaws    HTML     51K 
24: EX-3.25     Articles of Incorporation/Organization or Bylaws    HTML     39K 
25: EX-3.26     Articles of Incorporation/Organization or Bylaws    HTML     51K 
26: EX-3.27     Articles of Incorporation/Organization or Bylaws    HTML     42K 
27: EX-3.28     Articles of Incorporation/Organization or Bylaws    HTML     55K 
28: EX-3.29     Articles of Incorporation/Organization or Bylaws    HTML     60K 
 2: EX-3.3      Articles of Incorporation/Organization or Bylaws    HTML     60K 
29: EX-3.30     Articles of Incorporation/Organization or Bylaws    HTML     47K 
30: EX-3.31     Articles of Incorporation/Organization or Bylaws    HTML     62K 
31: EX-3.32     Articles of Incorporation/Organization or Bylaws    HTML     61K 
32: EX-3.33     Articles of Incorporation/Organization or Bylaws    HTML     75K 
33: EX-3.34     Articles of Incorporation/Organization or Bylaws    HTML     54K 
34: EX-3.35     Articles of Incorporation/Organization or Bylaws    HTML     41K 
35: EX-3.36     Articles of Incorporation/Organization or Bylaws    HTML     81K 
36: EX-3.37     Articles of Incorporation/Organization or Bylaws    HTML     47K 
37: EX-3.38     Articles of Incorporation/Organization or Bylaws    HTML     80K 
38: EX-3.39     Articles of Incorporation/Organization or Bylaws    HTML     45K 
 3: EX-3.4      Articles of Incorporation/Organization or Bylaws    HTML     68K 
39: EX-3.40     Articles of Incorporation/Organization or Bylaws    HTML     48K 
40: EX-3.41     Articles of Incorporation/Organization or Bylaws    HTML     35K 
41: EX-3.42     Articles of Incorporation/Organization or Bylaws    HTML     83K 
42: EX-3.43     Articles of Incorporation/Organization or Bylaws    HTML    188K 
43: EX-3.44     Articles of Incorporation/Organization or Bylaws    HTML     83K 
44: EX-3.45     Articles of Incorporation/Organization or Bylaws    HTML     42K 
45: EX-3.46     Articles of Incorporation/Organization or Bylaws    HTML    150K 
46: EX-3.47     Articles of Incorporation/Organization or Bylaws    HTML     56K 
47: EX-3.48     Articles of Incorporation/Organization or Bylaws    HTML     58K 
48: EX-3.49     Articles of Incorporation/Organization or Bylaws    HTML     44K 
 4: EX-3.5      Articles of Incorporation/Organization or Bylaws    HTML     33K 
49: EX-3.50     Articles of Incorporation/Organization or Bylaws    HTML     51K 
50: EX-3.51     Articles of Incorporation/Organization or Bylaws    HTML     62K 
51: EX-3.52     Articles of Incorporation/Organization or Bylaws    HTML     66K 
52: EX-3.53     Articles of Incorporation/Organization or Bylaws    HTML     31K 
53: EX-3.54     Articles of Incorporation/Organization or Bylaws    HTML     59K 
54: EX-3.55     Articles of Incorporation/Organization or Bylaws    HTML     43K 
55: EX-3.56     Articles of Incorporation/Organization or Bylaws    HTML     66K 
56: EX-3.57     Articles of Incorporation/Organization or Bylaws    HTML     35K 
57: EX-3.58     Articles of Incorporation/Organization or Bylaws    HTML     45K 
58: EX-3.59     Articles of Incorporation/Organization or Bylaws    HTML     65K 
 5: EX-3.6      Articles of Incorporation/Organization or Bylaws    HTML     81K 
59: EX-3.60     Articles of Incorporation/Organization or Bylaws    HTML     54K 
60: EX-3.61     Articles of Incorporation/Organization or Bylaws    HTML     32K 
61: EX-3.62     Articles of Incorporation/Organization or Bylaws    HTML     49K 
62: EX-3.63     Articles of Incorporation/Organization or Bylaws    HTML     96K 
63: EX-3.64     Articles of Incorporation/Organization or Bylaws    HTML     77K 
64: EX-3.65     Articles of Incorporation/Organization or Bylaws    HTML     56K 
65: EX-3.66     Articles of Incorporation/Organization or Bylaws    HTML     93K 
66: EX-3.67     Articles of Incorporation/Organization or Bylaws    HTML     50K 
67: EX-3.68     Articles of Incorporation/Organization or Bylaws    HTML     48K 
68: EX-3.69     Articles of Incorporation/Organization or Bylaws    HTML     33K 
 6: EX-3.7      Articles of Incorporation/Organization or Bylaws    HTML     30K 
69: EX-3.70     Articles of Incorporation/Organization or Bylaws    HTML     46K 
70: EX-3.71     Articles of Incorporation/Organization or Bylaws    HTML     35K 
71: EX-3.72     Articles of Incorporation/Organization or Bylaws    HTML     82K 
 7: EX-3.8      Articles of Incorporation/Organization or Bylaws    HTML     41K 
 8: EX-3.9      Articles of Incorporation/Organization or Bylaws    HTML     61K 
72: EX-4.8      Instrument Defining the Rights of Security Holders  HTML    732K 
73: EX-4.9      Instrument Defining the Rights of Security Holders  HTML    725K 
74: EX-5.1      Opinion of Counsel re: Legality                     HTML     40K 
75: EX-5.2      Opinion of Counsel re: Legality                     HTML     42K 
76: EX-5.3      Opinion of Counsel re: Legality                     HTML     48K 
77: EX-10.1     Material Contract                                   HTML    121K 
78: EX-10.2     Material Contract                                   HTML    121K 
79: EX-22.1     Published Report re: Matters Submitted to a Vote    HTML     39K 
                of Security Holders                                              
80: EX-23.1     Consent of Expert or Counsel                        HTML     30K 
81: EX-25.1     Statement of Eligibility to Act as a Trustee        HTML    104K 
84: EX-FILING FEES  Filing Fees                                     HTML     48K 
82: EX-99.1     Miscellaneous Exhibit                               HTML     78K 
83: EX-99.2     Miscellaneous Exhibit                               HTML     47K 


‘EX-5.1’   —   Opinion of Counsel re: Legality


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-5.1  

Exhibit 5.1

 

LOGO   

ROPES & GRAY LLP

PRUDENTIAL TOWER

800 BOYLSTON STREET

BOSTON, MA 02199-3600

WWW.ROPESGRAY.COM

January 5, 2024

IQVIA Inc.

2400 Ellis Road

Durham, North Carolina 27703

Ladies and Gentlemen:

We have acted as counsel to IQVIA Inc., a Delaware corporation (the “Company”), the Guarantors listed in Schedule I hereto (such listed guarantors the “Covered Guarantors”), and the Guarantors listed in Schedule II hereto (such listed guarantors the “Other Guarantors”, and together with the Covered Guarantors, the “Guarantors”), in connection with the Registration Statement on Form S-4 (the “Registration Statement”) filed by the Company and the Guarantors with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”). The Registration Statement includes a prospectus (the “Prospectus”) which provides for the issuance by the Company in an exchange offer (the “Exchange Offer”) of (i) $750,000,000 aggregate principal amount of 5.700% Senior Secured Notes due 2028 (the “2028 Registered Notes”), and (ii) $1,250,000,000 aggregate principal amount of 6.250% Senior Secured Notes due 2029 (the “2029 Registered Notes”, and, together with the 2028 Registered Notes, the “Registered Notes”). The Registered Notes will be offered by the Company in exchange for a like principal amount of the Company’s outstanding (i) 5.700% Senior Secured Notes due 2028 (the “2028 Restricted Notes”), and (ii) 6.250% Senior Secured Notes due 2029, respectively (the “2029 Restricted Notes”, and together with the 2028 Restricted Notes, the “Restricted Notes”). The 2028 Registered Notes are to be issued pursuant to an Indenture, dated as of May 23, 2023 (as amended, supplemented or modified through the date hereof, the “2028 Indenture”), between the Company, the Guarantors and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). The 2029 Registered Notes are to be issued pursuant to an Indenture, dated as of November 28, 2023 (as amended, supplemented or modified through the date hereof, the “2029 Indenture”, and together with the 2028 Indenture, the “Indentures”), between the Company, the Guarantors and the Trustee. Payment of the Registered Notes will be guaranteed by the Guarantors pursuant to Article 10 of the Indentures.


IQVIA Inc.    - 2 -   

 

In connection with this opinion letter, we have examined the Registration Statement and the Indentures, which have been filed with the Commission as exhibits to the Registration Statement. We have also examined such certificates, documents and records and have made such investigation of fact and such examination of law as we have deemed appropriate in order to enable us to render the opinions set forth herein. In conducting such investigation, we have relied, without independent verification, upon certificates of officers of the Company, Guarantors and other appropriate persons.

In rendering the opinions set forth below, we have assumed that the Other Guarantors listed in Schedule II hereto (a) are validly existing under the laws of their respective jurisdictions of organization, (b) have the power to execute and deliver the Indentures and the guarantees described therein (the “Guarantees”), and to perform their obligations thereunder and (c) have duly authorized, executed and delivered the Indentures and have duly authorized the Guarantees.

The opinions expressed herein are limited to matters governed by the laws of the State of New York, the State of Illinois, and the Commonwealth of Massachusetts and the Delaware General Corporation Law.

Based upon and subject to the foregoing and the qualifications and limitations set forth below, we are of the opinion that, when (i) the Guarantees have been duly executed and delivered in accordance with the provisions of the Indentures and (ii) the Registered Notes have been duly executed and authenticated in accordance with the provisions of the Indentures and have been delivered against receipt of the Restricted Notes surrendered in exchange therefor upon completion of the Exchange Offer, (a) the Registered Notes will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms and (b) the Guarantee by each Guarantor will constitute a valid and binding obligation of such Guarantor, enforceable against such Guarantor in accordance with its terms.

Our opinions set forth above are subject to (i) bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and similar laws affecting the rights and remedies of creditors generally, (ii) general principles of equity and (iii) the effects of the possible judicial application of foreign laws or foreign governmental or judicial action affecting creditors’ rights. We express no opinion with respect to the applicability of Section 548 of the federal Bankruptcy Code or any comparable provision of state law or the enforceability of the provisions contained in Section 10.02 of the Indentures which purport to limit the obligations of any Guarantor thereunder or the effect of the unenforceability of such provisions on the enforceability of the Guarantees.

Our opinions are also subject to the qualification that the enforceability of provisions in the Indenture providing for indemnification or contribution, broadly worded waivers, waivers of rights to damages or defenses, waivers of unknown or future claims, and waivers of statutory, regulatory or constitutional rights may be limited on public policy or statutory grounds. In addition, we express no opinion with respect to the enforceability of rights to receive prepayment premiums or the unaccrued portion of original issue discount upon acceleration, in each case to the extent determined to be unreasonable or to constitute a penalty or unmatured interest.

 

-2-


IQVIA Inc.    - 3 -   

 

We hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and the use of our name under the caption “Legal Matters” in the Prospectus. By giving the foregoing consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.

 

Very truly yours,
/s/ Ropes & Gray LLP
Ropes & Gray LLP

 

-3-


Schedule I

Covered Guarantors

BuzzeoPDMA LLC

Data Niche Associates, Inc.

IMS Software Services Ltd.

Intercontinental Medical Statistics International, Ltd.

IQVIA BioSciences Holdings, LLC

IQVIA Biotech LLC (f/k/a Novella Clinical LLC)

IQVIA Chinametrik Inc.

IQVIA Commercial Finance Inc.

IQVIA Commercial India Holdings Corp.

IQVIA Commercial Trading Corp.

IQVIA CSMS US Inc.

IQVIA Government Solutions Inc.

IQVIA Holdings Inc.

IQVIA Medical Education Inc.

IQVIA Trading Management Inc.

IQVIA Transportation Services Corp.

Med-Vantage, Inc.

Outcome Sciences, LLC

Q Squared Solutions Holdings LLC

RX India, LLC

Targeted Molecular Diagnostics, LLC

ValueMedics Research, LLC

VCG&A, Inc.

VCG-BIO, INC.


Schedule II

Other Guarantors

Benefit Holding, Inc.

Innovex Merger Corp.

IQVIA Medical Communications & Consulting, Inc.

IQVIA Pharma Inc.

IQVIA Pharma Services Corp.

IQVIA Phase One Services LLC

IQVIA RDS Asia Inc.

IQVIA RDS Inc.

IQVIA RDS Latin America LLC

Q Squared Solutions LLC

QCare Site Services, Inc.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-4’ Filing    Date    Other Filings
Filed on:1/5/24
11/28/238-K
5/23/238-K
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/15/24  IQVIA Holdings Inc.               10-K       12/31/23  163:19M
 1/18/24  IQVIA Holdings Inc.               S-4/A                  4:1.1M                                   Donnelley … Solutions/FA
 1/16/24  SEC                               UPLOAD2/21/24    2:56K  Outcome Sciences, LLC


20 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/28/23  IQVIA Holdings Inc.               8-K:1,2,8,911/28/23   12:2.8M                                   Donnelley … Solutions/FA
11/01/23  IQVIA Holdings Inc.               10-Q        9/30/23   83:7.2M
 9/26/23  IQVIA Holdings Inc.               8-K:5,7,9   9/24/23   11:156K                                   Donnelley … Solutions/FA
 8/01/23  IQVIA Holdings Inc.               10-Q        6/30/23   84:7.2M
 5/23/23  IQVIA Holdings Inc.               8-K:1,2,9   5/23/23   12:1.7M                                   Donnelley … Solutions/FA
 5/19/23  IQVIA Holdings Inc.               8-K:8,9     5/18/23   12:171K                                   Donnelley … Solutions/FA
 4/28/23  IQVIA Holdings Inc.               10-Q        3/31/23   78:6.3M
 4/18/23  IQVIA Holdings Inc.               8-K:1,2,9   4/17/23   11:2.5M
 4/18/23  IQVIA Holdings Inc.               8-K:5,9     4/18/23   12:417K                                   Broadridge Fin’l So… Inc
 2/27/23  IQVIA Holdings Inc.               DEF 14A               12:24M                                    Labrador Co./FA
 2/15/23  IQVIA Holdings Inc.               10-K       12/31/22  153:19M
 2/13/23  IQVIA Holdings Inc.               8-K:5,9     2/13/23   11:354K
 4/14/22  IQVIA Holdings Inc.               8-K:5,9     4/12/22   12:436K
 3/03/21  IQVIA Holdings Inc.               8-K:1,2,9   3/03/21   13:1.3M
 6/24/20  IQVIA Holdings Inc.               8-K:1,2,9   6/24/20   13:1.4M
 8/13/19  IQVIA Holdings Inc.               8-K:1,2,9   8/08/19   13:1M                                     Donnelley … Solutions/FA
 5/10/19  IQVIA Holdings Inc.               8-K:1,2,9   5/10/19    2:628K                                   Donnelley … Solutions/FA
 9/19/17  IQVIA Holdings Inc.               8-K:1,2,9   9/14/17    5:2.3M                                   Donnelley … Solutions/FA
10/03/16  IQVIA Holdings Inc.               8-K:1,2,3,5 9/30/16   17:4.2M                                   Donnelley … Solutions/FA
 4/26/13  IQVIA Holdings Inc.               S-1/A¶                 9:5.7M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-24-003405   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 7:01:35.2am ET